Thesis icon

Thesis

Development of chemogenetic methodology to investigate cortical mechanisms of cognition

Abstract:

DREADDs (designer receptors exclusively activated by designer drugs) are virally mediated engineered muscarinic receptors that no longer bind their endogenous ligand acetylcholine but instead bind the clozapine metabolite, clozapine-N-oxide (CNO). These receptors are a very useful research tool for deconstructing behaviour due to their promoter-driven cell- specificity and potential spatial resolution, the low invasiveness associated with their use, reversibility and the temporal resolutio...

Expand abstract

Actions

Access Document

Files:

Authors

More by this author
Division:
MSD
Department:
Pharmacology
Role:
Author

Contributors

Role:
Supervisor
ORCID:
0000-0001-7434-9713
Role:
Supervisor
Role:
Supervisor


DOI:
Type of award:
DPhil
Level of award:
Doctoral
Awarding institution:
University of Oxford


Language:
English
Keywords:
Pubs id:
2360227
Local pid:
pubs:2360227
Deposit date:
2020-07-02
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP